Therapeutic peptides: current applications and future directions
L Wang, N Wang, W Zhang, X Cheng, Z Yan… - Signal transduction and …, 2022 - nature.com
Peptide drug development has made great progress in the last decade thanks to new
production, modification, and analytic technologies. Peptides have been produced and …
production, modification, and analytic technologies. Peptides have been produced and …
In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives
Growing evidence suggests that T cells may play a critical role in combating severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Hence, COVID-19 vaccines that can …
respiratory syndrome coronavirus 2 (SARS-CoV-2). Hence, COVID-19 vaccines that can …
Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma
A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) is the source of a
current pandemic (COVID-19) with devastating consequences in public health and …
current pandemic (COVID-19) with devastating consequences in public health and …
Computationally optimized SARS-CoV-2 MHC class I and II vaccine formulations predicted to target human haplotype distributions
We present a combinatorial machine learning method to evaluate and optimize peptide
vaccine formulations for SARS-CoV-2. Our approach optimizes the presentation likelihood of …
vaccine formulations for SARS-CoV-2. Our approach optimizes the presentation likelihood of …
[HTML][HTML] Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmittable
and pathogenic human coronavirus that caused a pandemic situation of acute respiratory …
and pathogenic human coronavirus that caused a pandemic situation of acute respiratory …
Current and prospective computational approaches and challenges for developing COVID-19 vaccines
Abstract SARS-CoV-2, which causes COVID-19, was first identified in humans in late 2019
and is a coronavirus which is zoonotic in origin. As it spread around the world there has …
and is a coronavirus which is zoonotic in origin. As it spread around the world there has …
Immunoinformatics design of multivalent epitope vaccine against monkeypox virus and its variants using membrane-bound, enveloped, and extracellular proteins as …
Introduction The current monkeypox (MPX) outbreak, caused by the monkeypox virus
(MPXV), has turned into a global concern, with over 59,000 infection cases and 23 deaths …
(MPXV), has turned into a global concern, with over 59,000 infection cases and 23 deaths …
Vaccinomics: A future avenue for vaccine development against emerging pathogens
J de la Fuente, M Contreras - Expert Review of Vaccines, 2021 - Taylor & Francis
Introduction Vaccines are a major achievement in medical sciences, but the development of
more effective vaccines against infectious diseases is essential for prevention and control of …
more effective vaccines against infectious diseases is essential for prevention and control of …
Peptide-based vaccines and therapeutics for COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been prevalent in the
humans since 2019 and has given rise to a pandemic situation. With the discovery and …
humans since 2019 and has given rise to a pandemic situation. With the discovery and …
In silico and in vivo evaluation of SARS-CoV-2 predicted epitopes-based candidate vaccine
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, the causative agent of
coronavirus disease (COVID-19)) has caused relatively high mortality rates in humans …
coronavirus disease (COVID-19)) has caused relatively high mortality rates in humans …